mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0003 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |